Literature DB >> 8723419

ERCP: present practice in a single region. Suggested standards for monitoring performance.

A R Tanner1.   

Abstract

A survey of consecutive endoscopic retrograde cholangiopancreatography (ERCP) procedures has been undertaken for all the Units performing this procedure in the (old) Northern region of the UK. The process, imaging success, procedural success and complications have been analysed for 255 ERCP procedures. Overall, the results seem to be reassuring, with an imaging success rate of 88% (n = 297 ducts required), additional procedural success rate of 88% (n = 178) and with a serious complication rate of 6%. However, there are wide differences both in terms of practice (contrast agent used, antibody prophylaxis), imaging success (76-95%) and outcomes (procedure success 75-100%, serious complications 0-16%). This wide difference in practice seems difficult to justify. Individual Units should monitor their performance. Standards of practice are suggested for discussion and debate.

Mesh:

Substances:

Year:  1996        PMID: 8723419

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

Review 1.  Management of upper gastrointestinal cancers.

Authors:  A Melville; E Morris; D Forman; A Eastwood
Journal:  Qual Health Care       Date:  2001-03

2.  Objective evaluation of ERCP procedures: a simple grading scale for evaluating technical difficulty.

Authors:  K Ragunath; L A Thomas; W Y Cheung; P D Duane; D G Richards
Journal:  Postgrad Med J       Date:  2003-08       Impact factor: 2.401

3.  Diagnostic and therapeutic ERCP: a large single centre's experience.

Authors:  R J Farrell; N Mahmud; N Noonan; D Kelleher; P W Keeling
Journal:  Ir J Med Sci       Date:  2001 Jul-Sep       Impact factor: 1.568

4.  Complications of endoscopic retrograde cholangiography in the post-MRCP era: a tertiary center experience.

Authors:  Tze-Zen Ong; Jen-Lock Khor; Dede-Sutedja Selamat; Khay-Guan Yeoh; Khek-Yu Ho
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

5.  N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.

Authors:  Janusz Milewski; Grazyna Rydzewska; Malgorzata Degowska; Maciej Kierzkiewicz; Andrzej Rydzewski
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

6.  Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice.

Authors:  Earl J Williams; Steve Taylor; Peter Fairclough; Adrian Hamlyn; Richard F Logan; Derrick Martin; Stuart A Riley; Peter Veitch; Mark Wilkinson; Paula R Williamson; Martin Lombard
Journal:  Gut       Date:  2006-12-04       Impact factor: 23.059

7.  ERCP cannulation success benchmarking: implications for certification and validation.

Authors:  D P Sheppard; S J Craddock; B D Warner; M L Wilkinson
Journal:  Frontline Gastroenterol       Date:  2014-09-12

8.  An appraisal of endoscopic retrograde cholangiopancreatography (ERCP) for pancreaticobiliary disease in children: our institutional experience in 231 cases.

Authors:  Alana K Otto; Matthew D Neal; Adam N Slivka; Timothy D Kane
Journal:  Surg Endosc       Date:  2011-02-27       Impact factor: 4.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.